PharmaShots | Incisive News in 3 Shots

Subscribe Now

Newly Diagnosed

Takeda Reports Results of Ninlaro (ixazomib) in a P-III Clinical Study for Newly Diagnosed Multiple Myeloma

Takeda Reports Results of Ninlaro (ixazomib) in a P-III Clinical Study for Newly Diagnosed Multiple Myeloma

September 10, 2020

Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Janssen's Darzalex (daratumumab) Combination Regimen Receives EC's Approval for Transplant Eligible Patients with Newly Diagnosed...

January 21, 2020

Janssen's Darzalex (daratumumab) Combination Regimen Receives CHMP's Positive Opinion for Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

Janssen's Darzalex (daratumumab) Combination Regimen Receives CHMP's Positive Opinion for Transplant Eligible Patients with Newly...

December 13, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us